YOLFTbeta
Medicover AB Series B

Medicover AB Series B

0RPS · LSE

262.25SEK-4.75 (-1.78%)

Price History

Full chart

Market Stats

Previous Close267.00
Open263.75
Day Range262.25 – 263.75
52-Week Range177.73 – 262.00
Volume1.16K
Market Cap27.67B
P/E (TTM)4.34
Forward P/E0.00
EPS0.594
Dividend Yield0.68%
Beta1.50
50-Day Avg153.83
200-Day Avg150.14

About

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Company Details

  • CEOMr. John Paul Stubbington
  • Employees49.00K
  • HeadquartersRiddargatan 12A, Stockholm, Sweden, 102 46, UK
  • Websitehttps://www.medicover.com

Leadership

  • Mr. John Paul StubbingtonChief Executive Officer · b. 1968
  • Mr. Fredrik RagmarkExecutive Officer · b. 1963
  • Mr. Anand PatelChief Financial Officer · b. 1974
  • Hanna BjellquistHead of Investor Relations
  • Ms. Jenny BrandtGeneral Legal Counsel · b. 1974
  • Dr. Andrew Vallance-Owen FRCS Ed, MBAChief Marketing Officer · b. 1951
  • Ms. Kamila SkorupinskiChief People Officer · b. 1973
  • Mr. Staffan TernstromChief Operating Officer for Diagnostic Services · b. 1965
  • Mr. Lukasz KrauseChief Digital Information Officer

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue365.30M415.60M497.30M580.20M671.60M844.40M997.80M1.38B1.51B1.75B2.09B2.42B
Growth (%)-+13.77%+19.66%+16.67%+15.75%+25.73%+18.17%+38.04%+9.64%+15.64%+19.78%+15.82%
Cost of Revenue277.60M314.90M377.30M438.20M507.30M637.10M733.60M982.40M1.17B1.39B1.64B1.86B
Gross Profit87.70M100.70M120.00M142.00M164.30M207.30M264.20M395.00M340.10M359.40M448.30M561.02M
Gross Margin24.01%24.23%24.13%24.47%24.46%24.55%26.48%28.68%22.52%20.58%21.43%23.16%
Operating Expense70.90M79.20M98.90M113.20M128.80M157.60M202.90M235.60M284.90M298.00M378.00M402.41M
Operating Income16.80M21.50M21.10M28.80M35.50M49.70M61.30M159.40M55.20M61.40M70.30M158.62M
Operating Margin4.60%5.17%4.24%4.96%5.29%5.89%6.14%11.57%3.66%3.52%3.36%6.55%
EBITDA33.40M38.20M43.00M52.80M62.70M85.00M114.40M220.60M152.70M156.30M171.20M377.96M
EBITDA Margin9.14%9.19%8.65%9.10%9.34%10.07%11.47%16.02%10.11%8.95%8.18%15.60%
Net Income4.30M7.50M4.30M18.70M22.30M22.50M25.80M101.80M11.80M17.60M16.70M78.95M
Net Income Margin1.18%1.80%0.86%3.22%3.32%2.66%2.59%7.39%0.78%1.01%0.80%3.26%
R&D-----1.50M2.30M2.70M4.30M5.60M7.00M-
R&D as % of Total Revenue-----0.18%0.23%0.20%0.28%0.32%0.33%-
Interest Expense2.80M2.90M4.60M4.90M4.00M13.70M18.10M20.10M34.50M51.40M54.00M65.20M
Interest Expense % of Total Revenue0.77%0.70%0.92%0.84%0.60%1.62%1.81%1.46%2.28%2.94%2.58%2.69%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets269.60M312.80M419.50M503.80M728.40M1.02B1.11B1.68B1.83B1.94B2.14B2.41B
Total Liabilities179.10M219.60M320.70M199.80M410.90M663.40M627.40M1.12B1.32B1.41B1.65B1.87B
Total Equity88.60M89.20M92.70M300.30M313.10M317.40M448.00M517.60M472.40M496.50M464.80M530.95M
Cash11.80M17.20M18.40M45.40M38.40M34.80M46.70M81.90M40.40M50.80M82.80M82.01M
Total Debt110.70M140.90M210.10M57.20M256.70M451.50M367.40M764.10M940.00M1.00B1.24B1.91B
Net Debt98.90M123.70M191.70M11.80M218.30M416.70M286.30M636.10M840.00M952.90M1.16B1.83B

Cash Flow

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.70M28.70M25.90M50.30M74.40M87.30M155.10M2.23B1.90B205.00M261.90M292.38M
Investing Cash Flow-24.70M-45.60M-66.10M-53.50M-116.10M-141.80M-126.30M-333.60M-184.80M-119.80M-134.70M-340.67M
Financing Cash Flow4.10M22.60M41.50M31.30M34.60M48.80M-13.20M1.69B-271.48M-73.70M-108.00M64.38M
Capital Expenditure23.60M30.80M45.60M29.40M41.00M63.20M72.50M1.05B1.57B110.50M122.30M161.06M
Free Cash Flow-1.90M-2.10M-19.70M20.90M33.40M24.10M82.60M1.18B330.69M94.50M139.60M131.32M
Dividends Paid----10.40M10.40M10.40M107.08M198.86M17.90M18.00M22.92M
FCF to OCF-8.76%-7.32%-76.06%41.55%44.89%27.61%53.26%52.84%17.39%46.10%53.30%44.91%
Dividend Paid to FCF----31.14%43.15%12.59%9.08%60.14%18.94%12.89%17.46%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 9, 2024Apr 26, 2024Jul 25, 2024Oct 30, 2024Dec 31, 2024Apr 24, 2025Jul 24, 2025Nov 5, 2025Feb 10, 2026Apr 29, 2026Jul 22, 2026Nov 4, 2026
EPS Estimate--------------------------------0.110.110.090.120.180.19
EPS Actual0.130.290.660.670.510.440.260.480.330.460.52-0.06-0.591.121.261.762.071.261.880.860.11-0.260.140.110.42-0.080.890.470.48-0.340.661.501.391.441.361.561.76-
Surprise--------------------------------1160.27%1205.82%1414.89%1195.92%875.17%-
Timing--------------------------Pre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap27.67B
Enterprise Value40.97B
Trailing P/E4.34
Forward P/E0.00
Price / Sales11.63
Price / Book0.00
EPS0.594
Book Value3.53
Revenue (TTM)2.47B
Gross Profit (TTM)576.80M
EBITDA279.30M
Profit Margin3.44%
Operating Margin8.00%
Return on Equity15.49%
Return on Assets4.66%
Shares Outstanding133.34M
Shares Float53.13M
Beta1.50
Dividend Yield0.68%
Dividend Rate0.00
Payout Ratio35.52%

Dividends

20261×
2.17Apr 30, 2026
20251×
1.64Apr 30, 2025
20241×
1.41Apr 29, 2024
20231×
1.36Apr 28, 2023
20221×
1.24Apr 28, 2022
20211×
0.71Apr 30, 2021